Abiopharma

KING THOMAS BRAXTON 🟡 adjusted position in 139.9K shares (1 derivative) of ACHIEVE LIFE SCIENCES, INC. (ACHV) at $2.77 Transaction Date: Sep 04, 2025 | Filing ID: 113591

New Form SCHEDULE 13G - Health Catalyst, Inc. Filed: 2025-09-08 AccNo: 0000950170-25-113589 Size: 8 KB

New Form SCHEDULE 13G - SERA PROGNOSTICS, INC. Filed: 2025-09-08 AccNo: 0000950170-25-113590 Size: 8 KB

New Form 6-K - Pharvaris N.V. Filed: 2025-09-08 AccNo: 0001193125-25-198423 Size: 102 KB

JACOBS CINDY 🟡 adjusted position in 27.6K shares (2 derivative) of ACHIEVE LIFE SCIENCES, INC. (ACHV) at $2.77 Transaction Date: Sep 04, 2025 | Filing ID: 113588

New Form 8-K - Moleculin Biotech, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028572 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 6-K - BioNTech SE Filed: 2025-09-08 AccNo: 0001776985-25-000059 Size: 320 KB

New Form 8-A12B - BRUKER CORP Filed: 2025-09-08 AccNo: 0001140361-25-034302 Size: 18 KB

Tessari Eben 🟡 adjusted position in 98.7K shares (3 derivative) of Kiniksa Pharmaceuticals International, plc (KNSA) at $35.66 ($6.6M) Transaction Date: Sep 04, 2025 | Filing ID: 023878

New Form 8-K - Vaxart, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028570 Size: 186 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Carson Seana 🔴 sold 64.7K shares of Bausch Health Companies Inc. (BHC) at $7.35 Transaction Date: Sep 05, 2025 | Filing ID: 021221

Director Stapley Marc 🔴 sold 7.7K shares of VERACYTE, INC. (VCYT) at $30.41 Transaction Date: Sep 04, 2025 | Filing ID: 000124

New Form 8-K - NRX Pharmaceuticals, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028567 Size: 212 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Indivior Notification

New Form DEFA14A - Vaxart, Inc. Filed: 2025-09-08 AccNo: 0001437749-25-028566 Size: 22 KB